108 related articles for article (PubMed ID: 2527301)
21. Effects of a series of 4-alkyl analogues of 3,5-diethoxycarbonyl-1,4-dihydro-2,4,6-trimethylpyridine on the major inducible cytochrome P-450 isozymes of rat liver.
Riddick DS; Park SS; Gelboin HV; Marks GS
Mol Pharmacol; 1989 May; 35(5):626-34. PubMed ID: 2725472
[TBL] [Abstract][Full Text] [Related]
22. In vitro complex formation and inhibition of hepatic cytochrome P450 activity by different macrolides and tiamulin in goats and cattle.
Zweers-Zeilmaker WM; Van Miert AS; Horbach GJ; Witkamp RF
Res Vet Sci; 1999 Feb; 66(1):51-5. PubMed ID: 10088712
[TBL] [Abstract][Full Text] [Related]
23. Cytochrome P-450 complex formation by dirithromycin and other macrolides in rat and human livers.
Lindstrom TD; Hanssen BR; Wrighton SA
Antimicrob Agents Chemother; 1993 Feb; 37(2):265-9. PubMed ID: 8452357
[TBL] [Abstract][Full Text] [Related]
24. In vivo modulation of alternative pathways of P-450-catalyzed cyclophosphamide metabolism: impact on pharmacokinetics and antitumor activity.
Yu LJ; Drewes P; Gustafsson K; Brain EG; Hecht JE; Waxman DJ
J Pharmacol Exp Ther; 1999 Mar; 288(3):928-37. PubMed ID: 10027828
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic drug interactions of macrolides.
Periti P; Mazzei T; Mini E; Novelli A
Clin Pharmacokinet; 1992 Aug; 23(2):106-31. PubMed ID: 1511528
[TBL] [Abstract][Full Text] [Related]
26. 6-Methyl-1,3,8-trichlorodibenzofuran as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist: inhibition of the induction of rat cytochrome P-450 isozymes and related monooxygenase activities.
Astroff B; Zacharewski T; Safe S; Arlotto MP; Parkinson A; Thomas P; Levin W
Mol Pharmacol; 1988 Feb; 33(2):231-6. PubMed ID: 2828916
[TBL] [Abstract][Full Text] [Related]
27. Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man.
Watkins PB; Wrighton SA; Schuetz EG; Molowa DT; Guzelian PS
J Clin Invest; 1987 Oct; 80(4):1029-36. PubMed ID: 3654968
[TBL] [Abstract][Full Text] [Related]
28. Induction and activity of several isoenzymes of cytochrome P-450 in primary cultures of rat hepatocytes, in comparison with in vivo data.
Wortelboer HM; de Kruif CA; de Boer WI; van Iersel AA; Falke HE; Blaauboer BJ
Mol Toxicol; 1987-1988 Fall; 1(4):373-81. PubMed ID: 3509691
[TBL] [Abstract][Full Text] [Related]
29. [Comparative in vitro bacteriostatic and bactericidal effect of 5 macrolides: roxithromycin, erythromycin, oleandomycin, josamycin and spiramycin against 284 hospital bacterial strains].
Le Noc P; Croize J; Bryskier A; Le Noc D; Robert J
Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):553-9. PubMed ID: 2797879
[TBL] [Abstract][Full Text] [Related]
30. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
31. Oxidative metabolism of monensin in rat liver microsomes and interactions with tiamulin and other chemotherapeutic agents: evidence for the involvement of cytochrome P-450 3A subfamily.
Nebbia C; Ceppa L; Dacasto M; Carletti M; Nachtmann C
Drug Metab Dispos; 1999 Sep; 27(9):1039-44. PubMed ID: 10460804
[TBL] [Abstract][Full Text] [Related]
32. [Activity of the liver monooxygenase system after induction with phenobarbital in the early neonatal period].
Guliaeva LF; Mishin VM
Vopr Med Khim; 1985; 31(5):49-53. PubMed ID: 3937330
[TBL] [Abstract][Full Text] [Related]
33. Anti-inflammatory activity of macrolide antibiotics.
Ianaro A; Ialenti A; Maffia P; Sautebin L; Rombolà L; Carnuccio R; Iuvone T; D'Acquisto F; Di Rosa M
J Pharmacol Exp Ther; 2000 Jan; 292(1):156-63. PubMed ID: 10604943
[TBL] [Abstract][Full Text] [Related]
34. Cytochrome P4503A is the major source of N-vinylprotoporphyrin IX formation after administration of 3-[2-(2,4,6-trimethylphenyl)thioethyl]-4-methylsydnone to untreated and dexamethasone-pretreated rats.
McNamee JP; Marks GS
Drug Metab Dispos; 1996 Aug; 24(8):872-8. PubMed ID: 8869822
[TBL] [Abstract][Full Text] [Related]
35. Potentiation of 3-methylcholanthrene induction of rat hepatic cytochrome P450IA1 by dexamethasone in vivo.
Sherratt AJ; Banet DE; Linder MW; Prough RA
J Pharmacol Exp Ther; 1989 May; 249(2):667-72. PubMed ID: 2566684
[TBL] [Abstract][Full Text] [Related]
36. Induction of cytochrome P-450 isozymes in liver microsomes of rats treated with the cardiotonic agent sulmazole.
Müller-Enoch D; Dannan GA; Rudolf B; Friedl HP
Arzneimittelforschung; 1985; 35(4):698-703. PubMed ID: 4015736
[TBL] [Abstract][Full Text] [Related]
37. On the substrate specificity of cytochrome P450IIIA1.
Namkung MJ; Yang HL; Hulla JE; Juchau MR
Mol Pharmacol; 1988 Nov; 34(5):628-37. PubMed ID: 3264050
[TBL] [Abstract][Full Text] [Related]
38. Decrease in a constitutive form of cytochrome P-450 by macrolide antibiotics.
Miura T; Iwasaki M; Komori M; Ohi H; Kitada M; Mitsui H; Kamataki T
J Antimicrob Chemother; 1989 Oct; 24(4):551-9. PubMed ID: 2515189
[TBL] [Abstract][Full Text] [Related]
39. Identification of an inducible form of cytochrome P-450 in human liver.
Watkins PB; Wrighton SA; Maurel P; Schuetz EG; Mendez-Picon G; Parker GA; Guzelian PS
Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6310-4. PubMed ID: 3898085
[TBL] [Abstract][Full Text] [Related]
40. Drug interactions with macrolide antibiotics: specificity of pseudo-suicide inhibition and induction of cytochrome P-450.
Dansette PM; Delaforge M; Sartori E; Beaune P; Jaouen M; Mansuy D
Adv Exp Med Biol; 1986; 197():155-62. PubMed ID: 3490132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
